<DOC>
	<DOCNO>NCT01499290</DOCNO>
	<brief_summary>The purpose study evaluate effect Ceftazidime Avibactam plus Metronidazole compare Meropenem treat hospitalized patient complicate intra-abdominal infection .</brief_summary>
	<brief_title>Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem Hospitalized Adults With Complicated Intra-Abdominal Infections</brief_title>
	<detailed_description>A Phase III , Randomized , Multicenter , Double Blind , Double-Dummy , Parallel-Group , Comparative Study Determine Efficacy , Safety , Tolerability Ceftazidime Avibactam Plus Metronidazole Versus Meropenem Treatment Complicated Intra-Abdominal Infections In Hospitalized Adults</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<mesh_term>Avibactam</mesh_term>
	<mesh_term>Avibactam , ceftazidime drug combination</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>18 90 year age inclusive Female patient authorize participate least one follow criterion meet : 1 . Surgical sterilization 2 . Age ≥50 year postmenopausal define amenorrhea 12 month follow cessation exogenous hormonal treatment 3 . Age &lt; 50 year postmenopausal define documented LH FSH level postmenopausal range PLUS amenorrhea 12 month follow cessation exogenous hormonal treatment 4 . Patient negative serum pregnancy test ( serum ßhuman chorionic gonadotropin [ ßhCG ] ) within 1 day prior study entry , agree use highly effective contraception method treatment least 7 day last dose IV study therapy Intraoperative/postoperative enrollment confirmation ( presence pu within abdominal cavity ) intraabdominal infection associate peritonitis Confirmation infection surgical intervention within 24 hour entry : evidence systemic inflammatory response ; physical finding consistent intraabdominal infection ; supportive radiologic image finding intraabdominal infection Patient diagnose traumatic bowel perforation undergo surgery within 12 hour ; perforation gastroduodenal ulcer undergo surgery within 24 hour . Other intraabdominal process primary etiology likely infectious Patient abdominal wall abscess bowel obstruction without perforation ischemic bowel without perforation Patient suspect intraabdominal infection due fungus , parasite , virus tuberculosis Patient consider unlikely survive 6 8 week study period rapidly progressive terminal illness , include septic shock associate high risk mortality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Ceftazidime</keyword>
	<keyword>Meropenem</keyword>
	<keyword>Metronidazole</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
	<keyword>Anti-Infective Agents</keyword>
	<keyword>Antiprotozoal Agents</keyword>
	<keyword>Antiparasitic Agents</keyword>
	<keyword>cIAI , Complicated Intra-Abdominal Infection</keyword>
</DOC>